Acumen Pharmaceuticals, Inc. Interest Expense
Acumen Pharmaceuticals, Inc. (ABOS) reported Interest Expense of $1.00 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-14
- Acumen Pharmaceuticals, Inc. interest expense for the quarter ending 2024-03-31 was $1.00M.
- Acumen Pharmaceuticals, Inc. interest expense for the quarter ending 2023-03-31 was $0.00.
- Acumen Pharmaceuticals, Inc. interest expense for the quarter ending 2021-09-30 was $23.00K.
- Acumen Pharmaceuticals, Inc. interest expense for fiscal 2023 was $581.00K.
- Acumen Pharmaceuticals, Inc. interest expense for fiscal 2022 was $0.00.
| Period end | Interest Expense 3 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|
| 2024-03-31 | $1.00M 10-Q · filed 2024-05-14 | ||
| 2023-12-31 | $581.00K 10-K · filed 2024-03-26 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 | ||
| 2022-12-31 | $0.00 10-K · filed 2024-03-26 | ||
| 2021-09-30 | $23.00K 10-Q · filed 2021-11-15 | $23.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |